Clinical Trial Update: Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating paclitaxel, carboplatin, and panitumumab in metastatic breast cancer; the study was terminated but results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Panitumumab (panitumumab)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-06-18